Roberto Bolli, M.D., D.Sc. (Hon) FAHA, FACC

Robert Bolli, M.D.

Roberto Bolli, M.D., D.Sc. (Hon) FAHA, FACC

  • Professor of Medicine, Physiology and Biophysics
  • Jewish Hospital Heart and Lung Institute Distinguished Chair in Cardiology
  • Director, Institute of Molecular Cardiology
  • Distinguished University Scholar
UofL Physicians Outpatient Center
401 East Chestnut Street, Ste. 310
Louisville, KY 40202

502-852-1837- Academic Office
- Patient Appointments

Clinical Expertise
Cardiology; Cardiovascular Disease

Board Certification

  • American Board of Internal Medicine -
    Internal Medicine / Cardiovascular Disease

Education and Training

  • Medical School: University of Perugia
  • Residency: Baylor College of Medicine Affiliated Hospitals
  • Fellowship: National Institutes of Health; Baylor College of Medicine

Get To Know Dr. Bolli

Featured Publications

  • Bolli R, Tang XL. Clinical trials of cell therapy for heart failure: recent results warrant continued research. Curr Opin Cardiol. 2022 May 1;37(3):193-200. doi: 10.1097/HCO.0000000000000956. PMID: 35612934.
  • Ostovaneh MR, Ward C, Ambale-Venkatesh B, Chamera E, Kato Y, Bolli R, Mitrani R, Perin EC, Henry TD, Hare JM, Moyé L, Nazarian S, Lima JAC. Reproducibility of CMR in Patients With Cardiac Implantable Electrical Devices: Multicenter CONCERT-HF Trial. JACC Cardiovasc Imaging. 2022 May;15(5):952-954. doi: 10.1016/j.jcmg.2021.11.023. Epub 2022 Jan 12. PMID: 35033497.
  • Abouleisa RRE, Salama ABM, Ou Q, Tang XL, Solanki M, Guo Y, Nong Y, McNally L, Lorkiewicz PK, Kassem KM, Ahern BM, Choudhary K, Thomas R, Huang Y, Juhardeen HR, Siddique A, Ifthikar Z, Hammad SK, Elbaz AS, Ivey KN, Conklin DJ, Satin J, Hill BG, Srivastava D, Bolli R, Mohamed TMA. Transient Cell Cycle Induction in Cardiomyocytes to Treat Subacute Ischemic Heart Failure. Circulation. 2022 Apr 26;145(17):1339-1355. doi: 10.1161/CIRCULATIONAHA.121.057641. Epub 2022 Jan 21. PMID: 35061545; PMCID: PMC9038650.
  • Bolli R, Solankhi M, Tang XL, Kahlon A. Cell therapy in patients with heart failure: a comprehensive review and emerging concepts. Cardiovasc Res. 2022 Mar 16;118(4):951-976. doi: 10.1093/cvr/cvab135. PMID: 33871588; PMCID: PMC8930075.
  • Tang XL, Wysoczynski M, Gumpert AM, Li Y, Wu WJ, Li H, Stowers H, Bolli R. Effect of intravenous cell therapy in rats with old myocardial infarction. Mol Cell Biochem. 2022 Feb;477(2):431-444. doi: 10.1007/s11010-021-04283-2. Epub 2021 Nov 16. PMID: 34783963; PMCID: PMC8896398.
  • Bolli R, Tang XL. The sad plight of cell therapy for heart failure: causes and consequences. J Cardiovasc Aging. 2022;2:16. doi: 10.20517/jca.2022.02. Epub 2022 Mar 2. PMID: 35373217; PMCID: PMC8974963.
  • Li Q, Dasari C, Li D, Arshia A, Umer AM, Abouzid MRA, Guo Y, Bolli R. Effects of Heme Oxygenase-1 on c-Kit-Positive Cardiac Cells. Int J Mol Sci. 2021 Dec 15;22(24):13448. doi: 10.3390/ijms222413448. PMID: 34948245; PMCID: PMC8704354.
  • Zhang J, Bolli R, Garry DJ, Marbán E, Menasché P, Zimmermann WH, Kamp TJ, Wu JC, Dzau VJ. Basic and Translational Research in Cardiac Repair and Regeneration: JACC State-of-the-Art Review. J Am Coll Cardiol. 2021 Nov 23;78(21):2092-2105. doi: 10.1016/j.jacc.2021.09.019. PMID: 34794691; PMCID: PMC9116459.
  • Nong Y, Guo Y, Gumpert A, Li Q, Tomlin A, Zhu X, Bolli R. Single dose of synthetic microRNA-199a or microRNA-149 mimic does not improve cardiac function in a murine model of myocardial infarction. Mol Cell Biochem. 2021 Nov;476(11):4093-4106. doi: 10.1007/s11010-021-04227-w. Epub 2021 Jul 21. PMID: 34287784; PMCID: PMC8478849.
  • Abouleisa RRE, McNally L, Salama ABM, Hammad SK, Ou Q, Wells C, Lorkiewicz PK, Bolli R, Mohamed TMA, Hill BG. Cell cycle induction in human cardiomyocytes is dependent on biosynthetic pathway activation. Redox Biol. 2021 Oct;46:102094. doi: 10.1016/j.redox.2021.102094. Epub 2021 Aug 5. PMID: 34418597; PMCID: PMC8379496.